Late Recurrence of Light Chain Deposition Disease after Kidney Transplantation Treated with Bortezomib: A Case Report Article

PMID: 25249814 Web of Science: 000420374000025

Cited authors

  • Moiz, Abdul; Javed, Tariq; Garces, Jorge; Staffeld-Coit, Catherine; Paueksakon, Paisit


  • Background: Light chain deposition disease (LCDD) recurs frequently after renal transplantation with variable presentation.; Case Report: We report the case of a 67-year-old Caucasian female with recurrence of LCDD after living-donor kidney transplantation. Bone marrow biopsy revealed kappa light chain-restricted population of plasma cells, and the patient met the criteria for multiple myeloma. Her renal function progressively worsened and she became dialysis dependent. She received 1 cycle of bortezomib along with intravenous dexamethasone. She was able to discontinue dialysis within 2 months, and at 1 year follow-up her renal function was stable.; Conclusion: Bortezomib has a role in the treatment of recurrent LCDD and multiple myeloma in kidney transplant patients. As opposed to traditional regimens, a short course may be beneficial.

Publication date

  • 2014

Published in

International Standard Serial Number (ISSN)

  • 1524-5012

Start page

  • 445

End page

  • 449


  • 14


  • 3